EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells
- PMID: 9005992
- PMCID: PMC507791
- DOI: 10.1172/JCI119152
EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells
Abstract
The translocation t(11;22) is a common chromosomal abnormality detected both in Ewing's sarcoma and in primitive neuroectodermal tumor cells. The translocation results in an EWS-Fli1 fusion gene, made up of the 5' half of the EWS gene on chromosome 22 fused to the 3' half of the Fli1 gene on chromosome 11. Recent studies have evaluated possible roles of the fusion gene products. However, the biological significance of EWS-Fli1 is still unknown. Using a competitive polymerase chain reaction technique, we show here that there might be a correlation between the expression levels of the EWS-Fli1 fusion gene and the proliferative activities of Ewing's sarcoma and primitive neuroectodermal tumor cells. When the EWS-Fli1 expression is inhibited by antisense oligodeoxynucleotides against the fusion RNA, the growth of the tumor cells is significantly reduced both in vitro and in vivo. The data further indicate the growth inhibition of the cells by the antisense sequence might be mediated by G0/G1 block in the cell cycle progression. These results suggest that EWS-Fli1 may play an important role in the proliferation of the tumor cells, and the EWS-Fli1 fusion RNA could be used as a target to inhibit the growth of Ewing's sarcoma and primitive neuroectodermal tumor with the specific antisense oligonucleotide.
Similar articles
-
Biphenotypic sarcomas with myogenic and neural differentiation express the Ewing's sarcoma EWS/FLI1 fusion gene.Cancer Res. 1995 Mar 15;55(6):1385-92. Cancer Res. 1995. PMID: 7882340
-
EAT-2 is a novel SH2 domain containing protein that is up regulated by Ewing's sarcoma EWS/FLI1 fusion gene.Oncogene. 1996 Dec 19;13(12):2649-58. Oncogene. 1996. PMID: 9000139
-
Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study group.Klin Padiatr. 2004 Nov-Dec;216(6):315-22. doi: 10.1055/s-2004-832338. Klin Padiatr. 2004. PMID: 15565546
-
Biology of EWS/FLI and related fusion genes in Ewing's sarcoma and primitive neuroectodermal tumor.Curr Top Microbiol Immunol. 1997;220:143-50. Curr Top Microbiol Immunol. 1997. PMID: 9103680 Review. No abstract available.
-
Biology of EWS/ETS fusions in Ewing's family tumors.Oncogene. 2001 Sep 10;20(40):5747-54. doi: 10.1038/sj.onc.1204598. Oncogene. 2001. PMID: 11607824 Review.
Cited by
-
Establishment and characterization of a patient-derived metastatic extraskeletal Ewing sarcoma cell line ES-ZSS-1.Hum Cell. 2024 Oct 30;38(1):12. doi: 10.1007/s13577-024-01133-3. Hum Cell. 2024. PMID: 39475964
-
Detection of EWS/FLI-1 fusion in non-Ewing soft tissue tumors.J Med Life. 2015 Jan-Mar;8(1):85-9. J Med Life. 2015. PMID: 25914746 Free PMC article.
-
Exploiting Signaling Pathways and Immune Targets Beyond the Standard of Care for Ewing Sarcoma.Front Oncol. 2019 Jun 19;9:537. doi: 10.3389/fonc.2019.00537. eCollection 2019. Front Oncol. 2019. PMID: 31275859 Free PMC article. Review.
-
High ALDH activity identifies chemotherapy-resistant Ewing's sarcoma stem cells that retain sensitivity to EWS-FLI1 inhibition.PLoS One. 2010 Nov 11;5(11):e13943. doi: 10.1371/journal.pone.0013943. PLoS One. 2010. PMID: 21085683 Free PMC article.
-
PPP2R1A regulated by PAX3/FOXO1 fusion contributes to the acquisition of aggressive behavior in PAX3/FOXO1-positive alveolar rhabdomyosarcoma.Oncotarget. 2018 May 18;9(38):25206-25215. doi: 10.18632/oncotarget.25392. eCollection 2018 May 18. Oncotarget. 2018. PMID: 29861864 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources